Nasdaq
AUTL
Autolus Therapeutics plc
- Health Care
- United Kingdom
- Listed 2018
- 1 day
- +5.3%
- 1 month
- +24.2%
- 1 year
- −13.4%
$2.00 · Mkt cap $532M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Autolus Therapeutics plc
$2.00 · Mkt cap $532M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Autolus Therapeutics plc trades under the ticker AUTL on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2018. Its market capitalisation is $532M. The last closing price was $2.00, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −13.4%, and +24.2% over the past month. Returns are price returns and exclude dividends.
This page exists because AUTL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.